Company lists
The Chicago edition · 2026

Life sciencescompanies in Chicago

Research tools, oncology, neurology, genomics and health IT, startups and more: the companies building life sciences in Chicago, Illinois, with their founders, funding, team size and business models.

195 company profiles60 with recorded fundingNovember 2026 edition
Chicago · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent life sciences business events in the United States

Funding, M&A, contract wins and launches involving 27,407 life sciences companies in the United States, last 24 months: 1642 M&A deals · 1543 funding rounds · 557 Contracts · 73 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jul 2026.

LaunchRobotic Connective Network

Nightfood

Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…

Robotics
ContractInfrastructure

Sharp · client: Kddi

Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.

AI data center
M&AAcquisition · Completed

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquires Mineralys therapeutics

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the fourth quarter, according to its…

Clinical-stage biopharmaceutical
M&AMerger · Announced

Ignite acquires Ignite Proteomics

The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.

Functional proteomics
ContractTechnology

Chai Discovery · client: Pfizer

Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…

Biopharmaceutical
FundingSenior Notes

IQVIA

IQVIA Holdings Inc. ('IQVIA') (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the 'Issuer'), priced an offering of €950,000,000 in aggregate principal amount of…

ContractSupply

Beijing mabworks biotech · client: Everest medicines

Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…

Pharmaceutical
FundingSeries B

Advanced nanotherapies

Advanced NanoTherapies (ANT) has successfully closed a significant Series B funding round, garnering over $31 million.

Investors S3 Ventures, T45 Fund
Medical device
FundingRegistered Direct Offering

Lixte Biotechnology Holdings

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in…

Pharmaceutical
ContractService

Hollister-Stier Laboratories LLC · client: Biomarin pharmaceutical

Hollister-Stier has agreed to filter and package an enzyme-replacement product for BioMarin Pharmaceutical Inc., of Novato, Calif.

Pharmaceutical
M&AMerger · Completed

B&C Telephone Inc. acquires Intouch solutions

B&C Telephone Inc., a Spokane-based company that sells and services commercial telephone systems, has merged with inTouch Solutions, a Boise-based telecommunication company.

Telecommunications
M&AAcquisition · Announced

Resmed acquires Noctrix health

announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.

Medical technology
M&AAcquisition · Announced

The clorox company acquires Nutranext

Clorox will pay $700 million to acquire Nutranext, with the purchase price representing about 3.5 times calendar year 2017 sales.

Dietary and Nutritional Supplements
ContractService

Stellantis · client: Evera

With this agreement, Evera aims to rent 2,000 electric vehicles reconditioned by the Stellantis group by the end of 2027.

M&AAcquisition · Announced

Butterfly acquires Orgain

Butterfly, a LA-based private equity firm specializing in the food sector, has signed a definitive agreement to acquire a majority stake in Orgain, Inc., according to a press release.

Organic and clean nutrition products
FundingUnderwritten Offering

Mineralys therapeutics

The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be…

Investors BofA Securities, Goldman sachs, Evercore ISI
Biopharmaceutical
M&AAcquisition · Pending

Medtronic acquires Spr therapeutics

is currently finalizing the purchase of SPR Therapeutics

Medical device manufacturer
FundingPublic Offering

Avalo therapeutics

In first place was Avalo Therapeutics, which priced a $375 million public offering to advance the clinical development of its candidate abdakibart, including through its phase 3 topline…

Investors Na
Biotech
FundingPublic Offering

Editas medicine

In second place, gene editing company Editas Medicine announced a public offering of up to $319.4 million.

Investors Na
Biotech
FundingSeries A

Endra

Stockholm-based AI startup Endra has raised $50 million in Series A funding to scale its platform that automates design work for mechanical, electrical, and plumbing (MEP) consultants.…

Investors Andreessen Horowitz, Notion capital, Norrsken vc
AI
M&AAcquisition · Announced

Tend health acquires The doctors

On Tuesday, Tend Health announced an iwi-backed $270 million acquisition of The Doctors from NZX-listed Green Cross Health.

Medical and urgent care
LaunchVOXLS 20 C 225

Nikon Corporation

Nikon Corporation has launched the VOXLS 20 C 225, the latest addition to its VOXLS X-ray CT product lineup.

X-ray CT
FundingPublic Offering

Nrx pharmaceuticals

NRx Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock in an underwritten public offering with BTIG, LLC acting as the lead bookrunner and Lucid…

Investors BTIG, Lucid Capital
Biopharmaceutical
FundingNon-dilutive Capital

Apogee therapeutics

Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital last month from Blackstone Life Sciences, including up to $800 million in synthetic royalty and access to…

Investors Blackstone Life Sciences
Biotech
FundingPublic Offering

Artiva biotherapeutics

It's also worth noting that Artiva Biotherapeutics wasn't far behind in fourth place after pricing a $300 million underwritten offering.

Investors Na
Biotech
M&AAcquisition · Announced

Dragos acquires Phosphorus

Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.

Cybersecurity / device discovery and remediation software
M&AMerger · Announced

Avenzo therapeutics acquires Rallybio

NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).

Oncology
M&AAcquisition · Announced

Rallybio acquires Avenzo therapeutics

Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…

Biotech

Life sciences companies in Chicago, by funding and team

Few life sciences companies in Chicago, Illinois publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 195 active companies.

Showing 25 of 50

Developer of genomic testing and artificial intelligence tools for medicine

Artificial intelligence
US$760.00mSeries G · Oct 2022
3,157+2% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months

Provider of AI based drug discovery platform for drug development

Life sciences tech
US$345.00mSeries D · Apr 2025
100LinkedIn · Oct 2026
Subscription
4 yr2022
0none in 3 months · last posted Jun 2026

Developer of drugs for the treatment of endocrine disorders

Immunology
US$156.41mSeries B · Jun 2025
18+25% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months

Developer of liquid-stable injectables for the delivery of drugs

Drug delivery
US$155.44mSeries C · Mar 2018
532+63% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months · last posted Jun 2026

Developer of proteins using protein engineering technology

Life sciences tech
US$144.37mSeries B · Sep 2023
54-38% vs previous recordLinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months

Developer of biotech nano-particles for immune diseases

Oncology
US$135.20mSeries A · Jan 2024
31+35% 12 mo to Dec 2021recorded Dec 2021
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months

Developer of therapeutics to treat neurodegenerative diseases

Neurology
US$129.98mSeries B · Feb 2024
36-6% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
7 yr2019
0none in 3 months

Developer of plant breeding technologies for resilient and productive agri-food systems

Crop tech
US$121.70mSeries F · May 2017
92-6% 12 mo to Dec 2022recorded Dec 2022
Physical commerce
25 yr2001
0none in 3 months

AI-assisted platform for image analysis

Life sciences tech
US$58.50mSeries B · Apr 2024
67LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months

Developer of AI-based drug modality platform for protein-based drugs

Life sciences tech
US$34.00mSeries A · Apr 2025
30LinkedIn · Jul 2026
Commission on transaction / E-commerce - product
6 yr2020
0none in 3 months

Developer of a device for the treatment of malignant and benign breast tumors

Oncology
US$30.77mSeries B · Jan 2024
9LinkedIn · Jul 2026
Subscription
35 yr1991
0none in 3 months

Air disinfection and purification solutions for commercial, healthcare, and residential spaces

Hospital equipment
US$25.00mSeries B · Feb 2016
29+12% 12 mo to Dec 2019LinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months

Developer of therapeutics for treating cancer, metabolic diseases & musculoskeletal diseases

Oncology
US$25.00mSeries B · Oct 2022
26-82% vs previous recordLinkedIn · Jul 2026
Physical commerce / Fee-for-service
6 yr2020
0none in 3 months

Provider of digital depth gauge for the measurement of bones

Orthopedics
US$16.14mSeries A · Apr 2025
14LinkedIn · Jul 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months

Provider of 3D bio materials for regenerative medicine

3d printing
US$15.42mSeries A · Feb 2023
27+50% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Jun 2026

Developer of wearable sensor and AI platform for cardiac monitoring

Wearable technology
US$15.10mSeries A · Dec 2022
39-17% vs previous recordLinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Aug 2025

Developing personalized cellular therapies to transform transplant medicine and autoimmune disease treatment

Transplant medicine
US$15.00mSeries A · Apr 2019
4LinkedIn · Jul 2026
Fee-for-service
12 yr2014
0none in 3 months

Developer of therapeutics to treat inflammatory bowel disease and food allergy

Immunotherapy
US$14.44mSeries A · Sep 2022
14+20% vs previous recordLinkedIn · Jul 2026
Physical commerce
10 yr2016
0none in 3 months

Developer of cell-specific delivery systems and programmable cell engineering payloads

Genomics
US$13.66mSeries B · Jan 2025
18LinkedIn · Jul 2026
Physical commerce
4 yr2022
0none in 3 months

Developer of supramolecular therapeutic peptides for regenerative medicine applications

Neurology
US$12.50mSeed · Dec 2025
7LinkedIn · Jul 2026
E-commerce - product / Physical commerce
7 yr2019
0none in 3 months

Cloud based marketing solutions for life sciences companies

Life sciences tech
US$11.72mSeries A · Sep 2021
57+0% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
21 yr2005
0none in 3 months · last posted Jun 2026

Manufacturer of automated peritoneal dialysis system

Nephrology
US$11.67mSeries A · Mar 2024
6LinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months

Provider of 3D specimen radiography medical imaging devices

Imaging diagnostics
US$10.00mSeries A · Oct 2023
28+114% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
10 yr2016
0none in 3 months

Developer of an integrated management solution for hydrocephalus treatment optimization

Neurology
US$10.00mSeries A · Jan 2025
27LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Sep 2025

Sustainable microalgae growth platform transforming agricultural raw materials with innovative technology

Life sciences platforms and tools
US$8.71mSeries A · Apr 2020
1-27% vs previous recordLinkedIn · Jul 2026
Physical commerce
16 yr2010
—No postings tracked
50 of 195 companies shown here · the full list is on Radar
Fliar Radar

Explore all 195 life sciences companies in Chicago on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Chicago on Radar
  • Every company, not just 50All 195 life sciences companies in Chicago, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Chicago by what you are looking for

Browse top life sciences companies in Chicago across research, therapies, and medical technology. Find life sciences companies in Chicago for genomics and healthcare innovation.

7 ways to explore life sciences in Chicago

Life science platforms & research toolsOncology & cancer treatment companiesNeurology & brain health companiesGenomics & healthcare technologyLife sciences startups in ChicagoLife sciences companies hiring in Chicago

Life science platforms & research tools

Platforms and tools that support life science research and development.

  1. Pathos

    Provider of AI based drug discovery platform for drug development

    Life sciences tech
    See in list
  2. Evozyne

    Developer of proteins using protein engineering technology

    Life sciences tech
    See in list
  3. Nucle AI

    AI-assisted platform for image analysis

    Life sciences tech
    See in list
  4. Grove Biopharma

    Developer of AI-based drug modality platform for protein-based drugs

    Life sciences tech
    See in list
  5. ForeLight

    Sustainable microalgae growth platform transforming agricultural raw materials with innovative technology

    Life sciences platforms and tools
    See in list

Oncology & cancer treatment companies

Companies developing cancer diagnostics, therapies, and treatment tools.

  1. Pathos

    Provider of AI based drug discovery platform for drug development

    Life sciences tech
    See in list
  2. Cour Pharma

    Developer of biotech nano-particles for immune diseases

    Oncology
    See in list
  3. Novian Health

    Developer of a device for the treatment of malignant and benign breast tumors

    Oncology
    See in list
  4. Xentria

    Developer of therapeutics for treating cancer, metabolic diseases & musculoskeletal diseases

    Oncology
    See in list
  5. MAIA

    Developer of immunotherapeutic solutions for cancer treatment

    Oncology
    See in list

Neurology & brain health companies

Businesses developing treatments and tools for neurological conditions.

  1. Vanqua Bio

    Developer of therapeutics to treat neurodegenerative diseases

    Neurology
    See in list
  2. Amphix Bio

    Developer of supramolecular therapeutic peptides for regenerative medicine applications

    Neurology
    See in list
  3. Dystrogen Therapeutics

    Developing chimeric cell therapies for muscle wasting disorders like Duchenne Muscular Dystrophy

    Rare diseases
    See in list
  4. Neurodon

    Targeting cellular stress to revolutionize medicine with disease-modifying therapeutics

    Neurology
    See in list
  5. Beyond Barriers Therapeutics

    Develops therapeutics to reduce neural tissue damage after brain injury

    Life sciences platforms and tools

Genomics & healthcare technology

Companies using genomic data and software in healthcare.

  1. Tempus

    Developer of genomic testing and artificial intelligence tools for medicine

    Artificial intelligence
    See in list
  2. Chromatin

    Developer of plant breeding technologies for resilient and productive agri-food systems

    Crop tech
    See in list
  3. Syenex

    Developer of cell-specific delivery systems and programmable cell engineering payloads

    Genomics
    See in list
  4. OrisDX

    Developer of genomic-based diagnostic test for cancer

    Oncology
    See in list
  5. TorMagnus Pharmaceuticals

    Provider of bioinformatics solutions for drug development

    Life sciences tech
    See in list

Life sciences startups in Chicago

Newer life sciences companies founded in the past five years.

  1. Pathos

    Provider of AI based drug discovery platform for drug development

    Life sciences tech
    See in list
  2. Syenex

    Developer of cell-specific delivery systems and programmable cell engineering payloads

    Genomics
    See in list
  3. Flow Medical

    Developer of medical device for interventional pulmonary embolism treatment

    Pulmonology
    See in list
  4. OrisDX

    Developer of genomic-based diagnostic test for cancer

    Oncology
    See in list
  5. HumanImage

    Developer of three-dimensional imaging device for skin lesion and cancer tracking

    Dermatology
    See in list
32 companies in Chicago

Life sciences companies hiring in Chicago

Life sciences employers with active hiring signals.

  1. Pathos

    Provider of AI based drug discovery platform for drug development

    Life sciences tech
    See in list
  2. Xeris Pharmaceuticals

    Developer of liquid-stable injectables for the delivery of drugs

    Drug delivery
    See in list
  3. Dimension Inx

    Provider of 3D bio materials for regenerative medicine

    3d printing
    See in list
  4. Cardiosense

    Developer of wearable sensor and AI platform for cardiac monitoring

    Wearable technology
    See in list
  5. Vodori

    Cloud based marketing solutions for life sciences companies

    Life sciences tech
    See in list
12 companies in Chicago

Public life sciences companies in Chicago

Publicly listed life sciences companies in Chicago.

  1. Tempus

    Developer of genomic testing and artificial intelligence tools for medicine

    Artificial intelligence
    See in list
  2. Xeris Pharmaceuticals

    Developer of liquid-stable injectables for the delivery of drugs

    Drug delivery
    See in list
  3. MAIA

    Developer of immunotherapeutic solutions for cancer treatment

    Oncology
    See in list
  4. Wesana Health

    Developer of therapeutic solutions for the treatment of multiple neurological disorders

    Neurology
  5. Cell Biologics

    Manufacturer of primary cultured cells and cell culture products

    Life sciences platforms and tools
6 companies in Chicago
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Chicago compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, the United States1642

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in the United States

1363Acquisition
246Merger
14Takeover

Most active acquirers

  1. Eli lilly18
  2. Merck & Co. Inc.16
  3. Novartis15
  4. Boston scientific15
  5. Roche AG15

Most acquired or merged

  1. Bluebird bio14
  2. Teleflex11
  3. Staar surgical company10
  4. Exact sciences9
  5. Terns pharmaceuticals8

Each deal appears in the events strip at the top of the page.

Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of Chicago maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Chicago

Life sciences funding in Chicago

60 life sciences companies in Chicago have recorded equity funding, US$2.37bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Chicago

Meet the people behind life sciences companies in Chicago. 129 of 195 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Chicago life sciences companies by sub-sector

The most common specialisations among life sciences companies in Chicago. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Chicago

160 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Chicago

Browse the Radar directory

Coming soon